Threonine News and Research

RSS
The emergence and evolution of SARS-CoV-2 and its VOCs

The emergence and evolution of SARS-CoV-2 and its VOCs

Higher order protein catenation leads to the development of artificial antibodies

Higher order protein catenation leads to the development of artificial antibodies

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

Obtained SARS-CoV-2 immunity, naturally or via vaccination persists 12 months

SARS-CoV-2 variants and their ability to infect mice

SARS-CoV-2 variants and their ability to infect mice

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

Study explores therapeutic potential of exploiting autophagy cascade against COVID-19

Study explores therapeutic potential of exploiting autophagy cascade against COVID-19

Single mutation to bat virus spike protein allows cell entry using human ACE2

Single mutation to bat virus spike protein allows cell entry using human ACE2

Researchers identify common epitopes across SARS-CoV-2 viral variants

Researchers identify common epitopes across SARS-CoV-2 viral variants

Small molecule inhibitors of SARS-CoV-2 identified by screening

Small molecule inhibitors of SARS-CoV-2 identified by screening

Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals

Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals

SARS-CoV-2 mutation T478K spreading at alarming speed in Mexico

SARS-CoV-2 mutation T478K spreading at alarming speed in Mexico

New way to enhance treatment outcomes for breast cancer

New way to enhance treatment outcomes for breast cancer

Could an “ACE2 Triple Decoy” be an alternative approach to neutralizing SARS-CoV-2?

Could an “ACE2 Triple Decoy” be an alternative approach to neutralizing SARS-CoV-2?

Researchers identify human BCAS3 and C16orf70 as novel autophagic proteins

Researchers identify human BCAS3 and C16orf70 as novel autophagic proteins

Evolution of the spike gene of SARS-CoV-2 for human adaptation

Evolution of the spike gene of SARS-CoV-2 for human adaptation

SARS-CoV-2's resistance to remdesivir in vitro

SARS-CoV-2's resistance to remdesivir in vitro

Researchers call for trials of rapamycin to treat COVID-19

Researchers call for trials of rapamycin to treat COVID-19

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Advancements in research on cancer signal transduction and treatment

Advancements in research on cancer signal transduction and treatment